palmitoylcarnitine and Mitochondrial Diseases

palmitoylcarnitine has been researched along with Mitochondrial Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdul-Ghani, MA; Balas, B; Chang, Z; Chavez, AO; DeFronzo, RA; Folli, F; Jani, R; Liu, Y; Molina-Carrion, M; Monroy, A; Muller, FL; Tripathy, D; Van Remmen, H; Zuo, P	1
Bastin, J; Behin, A; Bonnefont, JP; Djouadi, F	1

Other Studies

2 other study(ies) available for palmitoylcarnitine and Mitochondrial Diseases

Article	Year
Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. American journal of physiology. Endocrinology and metabolism, 2008, Volume: 295, Issue:3 Topics: Acyl Coenzyme A; Adenosine Triphosphate; Adult; Animals; Fatty Acid Synthase, Type I; Fatty Acid Synthase, Type II; Fatty Acids; Glucose Tolerance Test; Humans; Insulin Resistance; Lipids; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mitochondria, Muscle; Mitochondrial Diseases; Muscle, Skeletal; Oxygen Consumption; Palmitoyl Coenzyme A; Palmitoylcarnitine; Pyruvates; Succinates	2008
Bezafibrate for an inborn mitochondrial beta-oxidation defect. The New England journal of medicine, 2009, Feb-19, Volume: 360, Issue:8 Topics: Adult; Bezafibrate; Carnitine O-Palmitoyltransferase; Genes, Recessive; Humans; Hypolipidemic Agents; Lipid Metabolism, Inborn Errors; Mitochondrial Diseases; Oxidation-Reduction; Palmitoylcarnitine; Pilot Projects; Quality of Life; Rhabdomyolysis; RNA, Messenger; Statistics, Nonparametric	2009

Article

Year

Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.

American journal of physiology. Endocrinology and metabolism, 2008, Volume: 295, Issue:3

Topics: Acyl Coenzyme A; Adenosine Triphosphate; Adult; Animals; Fatty Acid Synthase, Type I; Fatty Acid Synthase, Type II; Fatty Acids; Glucose Tolerance Test; Humans; Insulin Resistance; Lipids; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mitochondria, Muscle; Mitochondrial Diseases; Muscle, Skeletal; Oxygen Consumption; Palmitoyl Coenzyme A; Palmitoylcarnitine; Pyruvates; Succinates

2008

Bezafibrate for an inborn mitochondrial beta-oxidation defect.

The New England journal of medicine, 2009, Feb-19, Volume: 360, Issue:8

Topics: Adult; Bezafibrate; Carnitine O-Palmitoyltransferase; Genes, Recessive; Humans; Hypolipidemic Agents; Lipid Metabolism, Inborn Errors; Mitochondrial Diseases; Oxidation-Reduction; Palmitoylcarnitine; Pilot Projects; Quality of Life; Rhabdomyolysis; RNA, Messenger; Statistics, Nonparametric

2009